Kura Oncology Inc’s recently made public that its Chief Legal Officer Bair Teresa Brophy unloaded Company’s shares for reported $9292.0 on May 19 ’25. In the deal valued at $5.96 per share,1,559 shares were sold. As a result of this transaction, Bair Teresa Brophy now holds 107,948 shares worth roughly $0.61 million.
Then, FORD KATHLEEN sold 1,558 shares, generating $9,777 in total proceeds. Upon selling the shares at $6.28, the Chief Operating Officer now owns 21,367 shares.
Before that, FORD KATHLEEN bought 1,558 shares. Kura Oncology Inc shares valued at $9,286 were divested by the Officer at a price of $5.96 per share.
BTIG Research downgraded its Kura Oncology Inc [KURA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Stifel also remained covering KURA and has decreased its forecast on October 14, 2024 with a “Hold” recommendation from previously “Buy” rating. Mizuho started covering the stock on December 22, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Tuesday, Kura Oncology Inc [NASDAQ:KURA] saw its stock fall -0.53% to $5.61. Over the last five days, the stock has lost -10.10%. Kura Oncology Inc shares have fallen nearly -35.59% since the year began. Nevertheless, the stocks have fallen -75.12% over the past one year. While a 52-week high of $23.48 was reached on 02/05/25, a 52-week low of $5.41 was recorded on 04/07/25. SMA at 50 days reached $6.35, while 200 days put it at $11.81.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 5.47, which if violated will result in even more drops to 5.32. On the upside, there is a resistance level at 5.77. A further resistance level may holdings at 5.92. The Relative Strength Index (RSI) on the 14-day chart is 40.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.38%. Stochastics %K at 13.02% indicates the stock is a buying.
The most recent change occurred on August 11, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $31 price target.
